These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16375683)

  • 1. Endocannabinoids in neuroimmunology and stress.
    Carrier EJ; Patel S; Hillard CJ
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):657-65. PubMed ID: 16375683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the serotonin system by endocannabinoid signaling.
    Haj-Dahmane S; Shen RY
    Neuropharmacology; 2011 Sep; 61(3):414-20. PubMed ID: 21354188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
    Bisogno T; Di Marzo V
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary PUFAs and Exercise Dynamic Actions on Endocannabinoids in Brain: Consequences for Neural Plasticity and Neuroinflammation.
    Park Y; Watkins BA
    Adv Nutr; 2022 Oct; 13(5):1989-2001. PubMed ID: 35675221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders.
    Sharma DS; Paddibhatla I; Raghuwanshi S; Malleswarapu M; Sangeeth A; Kovuru N; Dahariya S; Gautam DK; Pallepati A; Gutti RK
    J Neuroimmunol; 2021 Apr; 353():577501. PubMed ID: 33571815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.
    Estrada JA; Contreras I
    Curr Neuropharmacol; 2020; 18(8):769-787. PubMed ID: 32065105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
    Tam J
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptors and endocannabinoids: evidence for new players.
    Mackie K; Stella N
    AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.
    Carrier EJ; Kearn CS; Barkmeier AJ; Breese NM; Yang W; Nithipatikom K; Pfister SL; Campbell WB; Hillard CJ
    Mol Pharmacol; 2004 Apr; 65(4):999-1007. PubMed ID: 15044630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of control of neuron survival by the endocannabinoid system.
    Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
    Curr Pharm Des; 2008; 14(23):2279-88. PubMed ID: 18781978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid overactivity and intestinal inflammation.
    Di Marzo V; Izzo AA
    Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid-mediated synaptic plasticity in the CNS.
    Chevaleyre V; Takahashi KA; Castillo PE
    Annu Rev Neurosci; 2006; 29():37-76. PubMed ID: 16776579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid system in Huntington's disease.
    Pazos MR; Sagredo O; Fernández-Ruiz J
    Curr Pharm Des; 2008; 14(23):2317-25. PubMed ID: 18781982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids and their role in fatty liver disease.
    Mallat A; Lotersztajn S
    Dig Dis; 2010; 28(1):261-6. PubMed ID: 20460921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid signaling in microglial cells.
    Stella N
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):244-53. PubMed ID: 18722389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
    Karanian DA; Bahr BA
    Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction.
    Newman Z; Malik P; Wu TY; Ochoa C; Watsa N; Lindgren C
    Eur J Neurosci; 2007 Mar; 25(6):1619-30. PubMed ID: 17408433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.